Ciencias Químicas
Faculty
Novartis (Sweden)
Täby, SueciaPublications in collaboration with researchers from Novartis (Sweden) (5)
2023
-
Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 4, pp. 1060-1072
2022
-
Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity?
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 11, pp. 3293-3308
2021
-
Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs
European Respiratory Journal
2019
-
IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy
Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1418-1429